Trials / Unknown
UnknownNCT05927831
Grape Seed Extract VS Low Level Laser Therapy for Dentin Hypersensitivity
Comparison of the Effectiveness of Grape Seed Extract (GSE) and Low-level Laser Therapy in the Management of Dentin Hypersensitivity: A Randomized Control Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Manipal University College Malaysia · Academic / Other
- Sex
- All
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Dentin hypersensitivity (DH) is a common clinical problem frequently seen in dental patients. According to Splieth et al., the prevalence of dentin hypersensitivity is 3-98% in adult population.DH is described as a short, sharp pain or discomfort that responses to certain stimuli, typically thermal, tactile, osmotic or chemical, due to exposed dentinal surface which can be explained by the hydrodynamic theory. The laser is a narrow, focused beam of light emitted to vaporise, fuse, melt, or seal dentinal tubules using laser heat to induce hydroxyapatite crystals for recrystallisation of the mineral component of dentine. The obliteration of dentinal tubules is caused by heat generated by laser beam which inhibits the transmission of the stimulus in the dentinal tubules. Grape seed extract contains proanthocyanidins (PA) which is able to bind to proline-rich proteins, like collagen, and contributes in enzyme proline hydroxylase activity that is essential for the biosynthesis of collagen in the dentin. The cross-linking action of collagen fibrils in dentin also able to prevent mineral loss.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Grape Seed Extract | Grape seed extract will be applied in the form of a gel on the tooth surface |
| DEVICE | Low-level laser therapy | The device will be set at a wavelength of 810 nm, with a power output of 0.5 watts tip of diameter 300 μ in non-contact mode |
Timeline
- Start date
- 2023-05-15
- Primary completion
- 2024-01-15
- Completion
- 2024-01-15
- First posted
- 2023-07-03
- Last updated
- 2023-07-03
Locations
1 site across 1 country: Malaysia
Source: ClinicalTrials.gov record NCT05927831. Inclusion in this directory is not an endorsement.